Viewing Study NCT00258804


Ignite Creation Date: 2025-12-24 @ 9:13 PM
Ignite Modification Date: 2026-01-25 @ 12:48 PM
Study NCT ID: NCT00258804
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2005-11-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Insulin Glargine During and After the Period of Fasting in Ramadan
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: HOE901_4055
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Medical Affairs Study Director
Old Organization: sanofi-aventis

Collaborators